Click here for a complete list of Clive Svendsen, PhD publications.

Selected Key Publications

Sofroneiw MV, Galletely NP, Isacson O, Svendsen CN. Basal forebrain neurons are not dependent upon target support for survival. Science. 1990;247:338-342.

Caldwell MA, He X, Wilkie N, Pollack S, Marshall G, Wafford K, Svendsen CN. Growth factors regulate the survival and fate of cells derived from human neurosphere cultures. Nature Biotechnology. 2001;19:475-479.

BahnS, Mimmack M, Ryan M, Caldwell MA, Starkey M, Jauniaux E, Svendsen CN, Emson P. Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down’s syndrome: a gene expression study. The Lancet. 2002;359:310-315.

Gill SS, Patel NK, Hotton GR, O’Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor (GDNF) in Parkinson’s Disease. Nature Medicine. 2003;9:589-595.

Ebert AD, Yu J, Rose F, Mattis VB, Lorson CL, Thomson JA, Svendsen CN. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2009;457:277-280.

Sareen D, Svendsen CN. Stem cell scientists sure play a mean pinball. Nature Biotechnology. 2010;28:333-5.

Kim, HW, Svendsen CN. Gene editing in stem cells hits the target. Cell Stem Cell. 2011;9:93-4.

Andres RH, Horie N, Slikker W, Keren-Gill H, Zhan K, Sun G, Manley NC, Pereira MP, Sheikh LA, McMillan EL, Schaar BT, Svendsen CN, Bliss TM, Steinberg GK. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain. 2011;134(Pt 6):1777-89.

Lindvall O, Barker RA, Brustle O, Isacson O, Svendsen, CN. Clinical translation of stem cells in neurodegenerative disorders. Cell Stem Cell. 2012;10:151-155.

The Huntington’s Disease iPS Consortium.* Induced pluripotent stem cells from patients with Huntington’s disease show CAG repeat-associated phenotypes. Cell Stem Cell. 2012;11:264-278. (*Svendsen CN corresponding author)